News Detail
New Delhi, 28 May 2024: A five-member expert committee will examine if manufacturing of nutraceuticals should be allowed within drug manufacturing facilities.
India's drug regulator had said earlier that action will be taken against those flouting norms by manufacturin......
View Details
Source : Economic Times
nutraceuticals
manufacturing
drug unit
committee
regulator
pharma lobbies
industry associations
supplements
health supplements
pharmaceutical companies
Related News
- Centre issues licences to 3,200 MedTech units; grants 10,000 import licences (26-07-2024)
- Maha FDA Seizes Rs 1.41 Crore Worth of Unlicensed Ayurvedic Drugs (26-07-2024)
- 424 drugs have been declared spurious/adulterated during 2022-23: Govt in LS (26-07-2024)
- ICMR releases 32 new treatment standards for treating common and serious diseases (26-07-2024)
- Indian national charged with selling counterfeit cancer drugs (26-07-2024)
- US FDA finds data integrity, sterility problems at Brassica Pharma (26-07-2024)
- DCA Raids Shops Selling Habit-Forming Drugs (25-07-2024)
- BIS Sanctioned 82 Medical Device projects to develop standards (25-07-2024)
- Anti-Narcotics Task Force will be formed soon in Rajasthan: HM (25-07-2024)
- ICMR to strengthen IPR unit to safeguard and commercialize scientific innovations (25-07-2024)